InspireMD Reports Third Quarter 2026 Financial Results
InspireMD Reports Third Quarter 2026 Financial Results - Received FDA approval of CGuard® Prime for
Related stories
FDA Declines to Approve Summit Lung Cancer Drug After Trial Misses Survival Goal
The FDA declined to approve Summit Therapeutics' lung cancer drug after its trial missed a key survival goal.
M impact | REGULATION | Nov 15, 2026, 01:20 PM UTC
US Judge Again Blocks Trump Plan to Renovate DC Golf Course
A US judge temporarily blocked the plan, according to the headline and available report text.
L impact | REGULATION | Nov 15, 2026, 02:35 AM UTC
UK to Expand Jobs Guarantee Scheme for Young People
The British government will expand its jobs guarantee scheme for young people.
L impact | REGULATION | Nov 14, 2026, 10:30 PM UTC
Italy Fines Meta $887 Million Over Use of Android Gallery Media
Italy announced an €805 million ($887 million) fine against Meta over its use of photos and videos from Android galleries on Facebook.
M impact | REGULATION | Nov 14, 2026, 05:53 PM UTC
Italy Fines Meta €805 Million Over Android Data Access
Italy’s privacy regulator fined Meta Platforms Ireland €805 million, finding it accessed photos, videos and related information stored on Android devices without specific user perm
M impact | REGULATION | Nov 14, 2026, 03:10 PM UTC
Meta fined €805 million in Italy
Meta must pay a €805 million fine in Italy, Reuters reports.
M impact | REGULATION | Nov 14, 2026, 02:44 PM UTC